On 26 JUNE Ardelyx Inc (NASDAQ:ARDX) said its major shareholder Ventures Vii Lp Cmea acquired 316,826 shares of Ardelyx stock in a transaction. The shares were purchased at an average price of $14.00 per share, with a total value of $4,435,564.00. The transaction was disclosed in a filing with the Securities & Exchange Commission. Ardelyx Inc (NASDAQ:ARDX) net profit margin is -33.00% and weekly performance is 12.21%. On last trading day company shares ended up $17.74. Ardelyx Inc (NASDAQ:ARDX) distance from 50-day simple moving average (SMA50) is 15.86%.
On 26 JUNE Omeros Corporation (NASDAQ:OMER) said it was a big mover last session, as the company saw its shares rise. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. Omeros Corporation (NASDAQ:OMER) shares advanced 3.97% in last trading session and ended the day on $18.09. OMER return on assets is -170.50%. Omeros Corporation (NASDAQ:OMER) quarterly performance is 44.95%.
On 12 JUNE Albany Molecular Research, Inc. (NASDAQ:AMRI) reported $0.16 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.23 by $0.07. The company had revenue of $51.00 million for the quarter, compared to the consensus estimate of $62.19 million. Analysts expect that Albany Molecular Research will post $0.82 EPS for the current fiscal year. Albany Molecular Research, Inc. (NASDAQ:AMRI) shares moved up 5.77% in last trading session and was closed at $21.28, while trading in range of $20.14 – $21.50. Albany Molecular Research, Inc. (NASDAQ:AMRI) year to date (YTD) performance is 111.11%.
On 19 JUNE Celgene Corporation (NASDAQ:CELG) announced that its stockholders approved a two-for-one stock split and an increase from 575 million to 1,150 million in the number of authorized shares of the Company’s common stock at the Company’s Annual Meeting of Stockholders on June 18, 2014. Celgene Corporation (NASDAQ:CELG) ended the last trading day at $88.50. Company weekly volatility is calculated as 2.09% and price to cash ratio as 13.82. Celgene Corporation (NASDAQ:CELG) showed a positive weekly performance of 3.26%.
On 30 JUNE Repligen Corporation (NASDAQ:RGEN) reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.07 by $0.06. The company had revenue of $16.33 million for the quarter, compared to the consensus estimate of $15.14 million. Repligen Corp.’s revenue was down .8% compared to the same quarter last year. On average, analysts predict that Repligen Corp. will post $0.29 earnings per share for the current fiscal year. Repligen Corporation (NASDAQ:RGEN) net profit margin is 26.50% and weekly performance is 8.85%. On last trading day company shares ended up $23.85. Analysts mean target price for the company is $23.67. Repligen Corporation (NASDAQ:RGEN) distance from 50-day simple moving average (SMA50) is 26.93%.
Leave a Reply